Abstract
A review article is devoted to diagnostical etiopathogenetic criteria of hepatoblastoma in pediatric patients. There is a distinguished cytogenetic analysis that detects only a limited amount of structural and numerical anomalies in hepatoblastomas; histopathological assessment of liver bioptats which facilitates treatment tactics. Distinctive laboratory findings in pediatric hepatoblastoma are microcytic anaemia, reactive thrombocytosis, and elevated alpha-fetoprotein. The immunohistochemical analysis allows the assessment of the nuclear expression of INI1 (SMARCB1) and the exclusion of malignant rhabdoid liver tumours. There is recommended hepatic doppler ultrasonography, as well as a three-dimensional assessment of primary tumour sizes and tumour volume to reveal the extent of hepatoblastoma according to the PRETEXT system. Radiography and computed tomography of the chest organs are advised to determine hepatoblastoma’s metastases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
